Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sugar

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
Schizophrenia Research|November 30, 2014
Neurocognitive performance in family-based and case-control studies of schizophreniaRuben C Gur, David L Braff, Monica E Calkins, et al.
JAMA Psychiatry|December 8, 2016
Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in SchizophreniaMichael L Thomas, Michael F Green, Gerhard Hellemann, et al.
Nature Cancer|November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor ImmunityWon Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Schizophrenia Research|January 3, 2015
Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategiesAllen D Radant, Steven P Millard, David L Braff, et al.
Molecular Autism|March 22, 2022
The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trialsFrederick Shic, Adam J Naples, Erin C Barney, et al.
Psychiatry Research|June 11, 2014
Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblingsJames Schmeidler, Laura C Lazzeroni, Neal R Swerdlow, et al.
Schizophrenia Research|April 15, 2008
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of SchizophreniaWilliam P Horan, David L Braff, Keith H Nuechterlein, et al.
The American Journal of Psychiatry|March 21, 2013
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of SchizophreniaTiffany A Greenwood, Neal R Swerdlow, Raquel E Gur, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
Schizophrenia Research|November 30, 2014
Neurocognitive performance in family-based and case-control studies of schizophreniaRuben C Gur, David L Braff, Monica E Calkins, et al.
JAMA Psychiatry|December 8, 2016
Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in SchizophreniaMichael L Thomas, Michael F Green, Gerhard Hellemann, et al.
Nature Cancer|November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor ImmunityWon Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Schizophrenia Research|January 3, 2015
Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategiesAllen D Radant, Steven P Millard, David L Braff, et al.
Molecular Autism|March 22, 2022
The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trialsFrederick Shic, Adam J Naples, Erin C Barney, et al.
Psychiatry Research|June 11, 2014
Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblingsJames Schmeidler, Laura C Lazzeroni, Neal R Swerdlow, et al.
Schizophrenia Research|April 15, 2008
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of SchizophreniaWilliam P Horan, David L Braff, Keith H Nuechterlein, et al.
The American Journal of Psychiatry|March 21, 2013
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of SchizophreniaTiffany A Greenwood, Neal R Swerdlow, Raquel E Gur, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Pageof 34